Outlook Therapeutics, Inc.OTLKNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Trend
Above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
0.00%
↑ 100% above average
Average (39q)
-23.38%
Historical baseline
Range
High:82.00%
Low:-645.67%
Volatility
-3112.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -27.09% |
| Q1 2025 | 42.65% |
| Q4 2024 | 5.55% |
| Q3 2024 | -16.94% |
| Q2 2024 | -3.29% |
| Q1 2024 | -83.47% |
| Q4 2023 | 17.14% |
| Q3 2023 | 31.32% |
| Q2 2023 | -165.30% |
| Q1 2023 | 56.41% |
| Q4 2022 | -12.15% |
| Q3 2022 | 17.83% |
| Q2 2022 | 9.97% |
| Q1 2022 | -43.80% |
| Q4 2021 | 2.13% |
| Q3 2021 | -17.09% |
| Q2 2021 | 9.11% |
| Q1 2021 | 11.04% |
| Q4 2020 | -41.71% |
| Q3 2020 | 15.70% |
| Q2 2020 | -75.62% |
| Q1 2020 | 17.35% |
| Q4 2019 | 35.52% |
| Q3 2019 | -124.88% |
| Q2 2019 | 26.76% |
| Q1 2019 | 24.87% |
| Q4 2018 | 17.38% |
| Q3 2018 | -71.94% |
| Q2 2018 | -5.69% |
| Q1 2018 | -114.81% |
| Q4 2017 | -22.21% |
| Q3 2017 | 64.53% |
| Q2 2017 | 6.40% |
| Q1 2017 | 55.95% |
| Q4 2016 | -71.70% |
| Q3 2016 | 52.95% |
| Q2 2016 | -645.67% |
| Q1 2016 | 82.00% |
| Q4 2015 | 5.52% |